생화학분자생물학회입니다.
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
작성자
Hyukjin Lee작성일자
2023-12-21조회수
681![]() |
Hyukjin Lee( hyukjin@ewha.ac.kr ) | |
2021-present | Professor, College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University | |
2017-2021 | Associate Professor, College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University | |
2012-2017 | Assistant Professor, College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University | |
2010-2012 | Postdoctoral Associate, Koch Institute of Integrated Cancer Research, MIT, MA, USA | |
2009-2010 | Postdoctoral Fellow, Department of Chemistry, KAIST, Daejeon | |
2005-2009 | Ph.D, Biological Sciences (Drug delivery and Bioconjugate Chemistry), Korea Advanced Institute of Science and Technology, Daejeon, South Korea | |
2003-2004 | MS, Biomedical Engineering (Cartilage Tissue Engineering), Columbia University, NY, USA |
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Several studies have utilized a lipid nanoparticle delivery system to enhance the effectiveness of mRNA therapeutics and vaccines. However, these nanoparticles are recognized as foreign materials by the body and stimulate innate immunity, which in turn impacts adaptive immunity. Therefore, it is crucial to understand the specific type of innate immune response triggered by lipid nanoparticles. This article provides an overview of the immunological response in the body, explores how lipid nanoparticles activate the innate immune system, and examines the adverse effects and immunogenicity-related development pathways associated with these nanoparticles. Finally, we highlight and explore strategies for regulating the immunogenicity of lipid nanoparticles.
Exp Mol Med. 2023 Oct;55(10):2085-2096. doi: 10.1038/s12276-023-01086-x
https://www.nature.com/articles/s12276-023-01086-x